Posted: Feb 21, 2012 8:09 AM by Associated Press (DS)
Updated: Feb 22, 2012 12:19 PM
TRENTON, N.J. (AP) - Federal regulators say they've approved new suppliers for two crucial cancer drugs, easing critical shortages - at least for the time being - that have patients worried about missing life-saving treatments.
The Food and Drug Administration will temporarily allow importation of a replacement drug for Doxil, a drug for ovarian and other cancers that hasn't been available for new patients for months.
The agency also has approved another supplier for a preservative-free version of methotrexate (METH-oh-TRECKS-ayt), a crucial drug for children with a type of leukemia and for high-dose treatment of bone cancer.
The FDA increasingly has been able to prevent drug shortages by getting advance notice from manufacturers, but about 280 drugs currently are in short supply.
PLEASE HELP US MODERATE COMMENTS
Offensive or inappropriate comments are subject to removal. To report a comment, please e-mail us at feedback@ksby.com, and include the name of the story and information on the comment.
Thank you! KSBY.com
The California Mid-State Fair is just around the corner. See what's coming up!
Wondering what to do this weekend? Check out our calendar of events across the Central Coast.
Did you win? Check your numbers here. KSBY, the official CA Lottery station for the Central Coast.
Comments